| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000114304 |
| P698 | PubMed publication ID | 4363875 |
| P2093 | author name string | Roos BE | |
| Johannsson B | |||
| P433 | issue | 1 | |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| patient | Q181600 | ||
| P304 | page(s) | 37-45 | |
| P577 | publication date | 1974-01-01 | |
| P1433 | published in | European Neurology | Q1376833 |
| P1476 | title | 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases | |
| P478 | volume | 11 |
| Q66936382 | 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid in consciousness and unconsciousness after head injury |
| Q67020559 | A comparison between fluorometric and mass fragmentographic determinations of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid |
| Q60619450 | Altered serotonin uptake kinetics in multiple sclerosis |
| Q52009105 | Application of weak electromagnetic fields facilitates sensory-motor integration in patients with multiple sclerosis. |
| Q39561650 | Biochemical pharmacology of Gilles de la Tourette's syndrome |
| Q37057057 | CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders |
| Q36681597 | Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields |
| Q46688212 | Coexisting bipolar affective disorder and multiple sclerosis: the role of the pineal gland |
| Q66963759 | Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid |
| Q34249660 | Dopaminergic dysfunction in tourette syndrome |
| Q67356828 | Effects of L-tryptophan treatment on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis |
| Q45306460 | Friedreich's ataxia in the south of Italy: a clinical and biochemical survey of 23 patients. |
| Q40555514 | Gilles de la Tourette syndrome: Further studies and thoughts |
| Q52000784 | Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. |
| Q52214843 | Improvement by picoTesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis. |
| Q52056215 | Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields. |
| Q35223132 | L-Tryptophan in Neuropsychiatry Disorders: A Review |
| Q41069606 | Long term beneficial effects of weak electromagnetic fields in multiple sclerosis |
| Q40690942 | Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis |
| Q28340511 | Mass fragmentography of 5-hydroxytryptophol and 5-methoxytryptophol in human cerebrospinal fluid |
| Q37054783 | Monoamine metabolites in cerebrospinal fluid in multiple sclerosis |
| Q48223458 | Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields |
| Q50607498 | Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. |
| Q45303775 | Neurotransmitters in Huntington's Chorea—a Clinician's View |
| Q35223138 | Nocturnal Plasma Melatonin and Alpha-Melanocyte Stimulating Hormone Levels During Exacerbation of Multiple Sclerosis |
| Q40690936 | Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders |
| Q48417190 | On the nature of brain stem disorders in severe head injured patients |
| Q73503025 | Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis |
| Q39591213 | Pathophysiology and Pharmacotherapy of Spasmodic Torticollis: A Review |
| Q48837691 | Rapid normalization of visual evoked potentials by picoTesla range magnetic fields in chronic progressive multiple sclerosis |
| Q48280329 | Resolution of longstanding symptoms of multiple sclerosis by application of picoTesla range magnetic fields |
| Q41628283 | Resolution of sleep paralysis by weak electromagnetic fields in a patient with multiple sclerosis |
| Q48333540 | Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis |
| Q33841831 | Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis |
| Q72735554 | Serotonin binding sites I. structures of sites on myelin basic protein, LHRH, MSH, ACTH, interferon, serum albumin, ovalbumin and red pigment concentrating hormone |
| Q39551919 | Serotonin in involuntary movement disorders |
| Q37048697 | Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man |
| Q48901087 | Suicidal behavior is attenuated in patients with multiple sclerosis by treatment with electromagnetic fields |
| Q48505011 | The Pineal Gland and Multiple Sclerosis |
| Q45095011 | The Pineal Gland in Multiple Sclerosis |
| Q48114673 | The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link |
| Q41163471 | The pineal gland, cataplexy, and multiple sclerosis |
| Q40278522 | Tourette's syndrome in a black woman with associated triple X and 9p mosaicism |
| Q48498380 | Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis |
| Q41128782 | Tryptophan availability and the susceptibility to stress in multiple sclerosis: a hypothesis |
| Q48595016 | Visual averaged evoked responses (aer) and monoamine metabolites in cerebrospinal fluid (csf) |
| Q48821860 | Weak Electromagnetic Fields Restore Dream Recall in Patients with Multiple Sclerosis |
| Q48333543 | Yawning and stretching--a behavioral syndrome associated with transcranial application of electromagnetic fields in multiple sclerosis |
Search more.